<DOC>
	<DOCNO>NCT01509612</DOCNO>
	<brief_summary>The investigator aim investigate validity previous result randomize prospective , placebo-controlled , double-blind , multicenter control evaluation questionnaire patient advance malignant tumor . The investigator plan compare treatment outcome ( quality life survival ) tumor patient , receive standard `` add-on '' homeopathic treatment . The null hypothesis `` add-on '' homeopathic treatment create benefit cancer patient . In addition investigator evaluate survival time .</brief_summary>
	<brief_title>Additive Homeopathy Cancer Patients</brief_title>
	<detailed_description>The EORTC-QLQ-C30 well VAS scale subjective well-being fill patient .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Informed consent Clinical diagnosis advance tumor stage glioblastoma IV , metastasize sarcoma , well non smallcell lung carcinoma ( NSCLC ) IV . Pregnant patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>cancer</keyword>
	<keyword>additive homeopathy</keyword>
	<keyword>patient advance malignant tumor</keyword>
</DOC>